Nomura Holdings
ONCT

Nomura Holdings’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Nomura Holdings’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24
Closed -$29K – 2147
2015
Q3 		$29K Sell
24
-27
-53% -$39.5K ﹤0.01% 1573
2015
Q2 		$105K Buy
+51
New +$72.5K ﹤0.01% 1663
2013
Q4 		– Sell
-46
Closed -$142K – 2394
2013
Q3 		$142K Buy
46
+34
+283% +$169K ﹤0.01% 2003
2013
Q2 		$110K Buy
+12
New +$92.5K ﹤0.01% 1980

Other funds holding ONCT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Nomura Holdings's ONCT Position: Q4 2015 in Review

Nomura Holdings sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2015, closing a stake of 24 shares — an estimated $29K sold.

Nomura Holdings first reported a position in ONCT in Q2 2013 and held it in 4 quarters. The position peaked at $142K in Q3 2013. 39 funds tracked by Wall St. Rank hold ONCT as of Q4 2015.

  • Nomura Holdings reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Nomura Holdings sold 24 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $29K.
  • Nomura Holdings first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 4 quarters.
  • Nomura Holdings's Oncternal Therapeutics, Inc. Common Stock position peaked at $142K in Q3 2013.
  • 39 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Nomura Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.